Serum testosterone levels during early pregnancy in patients developing preeclampsia
Abstract
OBJECTIVE: The purpose of the present study was to elucidate the possible association between hyperandrogenemia and preeclampsia by analysing serum testosterone (T) in pregnant women with a specific liquid chromatography tandem mass spectrometric (LC-MS/MS) method.
STUDY DESIGN: Serum levels of T, sex hormone binding globulin (SHBG) and testosterone/sex hormone binding globulin-ratio (T/SHBG-ratio) were determined during the first and second trimester in pregnancy from 91 pregnant women who later developed preeclampsia and from 182 healthy controls.
RESULTS: There were no significant differences in serum T levels measured by LC-MS/MS between the patients and matched controls. The fetal gender had no influence on serum hormone levels or differences between the groups. Nor were there any significant differences in individual changes of hormones between the two sample taking periods. The results were unaffected by the matching of maternal body mass index (BMI) or other interfering factors such as parity, maternal age at the sample collection time and maternal smoking in multiple regression analyses.
CONCLUSION: The concentrations of serum T, SHBG and the T/SHBG-ratio in early pregnancy do not predict the development of preeclampsia.
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 91 participants or records.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.